Neuroanatomical heterogeneity of essential tremor according to propranolol response

PLoS One. 2013 Dec 16;8(12):e84054. doi: 10.1371/journal.pone.0084054. eCollection 2013.

Abstract

Background: Recent studies have suggested that essential tremor (ET) is a more complex and heterogeneous clinical entity than initially thought. In the present study, we assessed the pattern of cortical thickness and diffusion tensor white matter (WM) changes in patients with ET according to the response to propranolol to explore the pathogenesis underlying the clinical heterogeneity of ET.

Methods: A total of 32 patients with drug naive ET were recruited prospectively from the Movement Disorders outpatient clinic. The patients were divided into a propranolol-responder group (n = 18) and a non-responder group (n = 14). We analyzed the pattern of cortical thickness and diffusion tensor WM changes between these two groups and performed correlation analysis between imaging and clinical parameters.

Results: There were no significant differences in demographic characteristics, general cognition, or results of detailed neuropsychological tests between the groups. The non-responder group showed more severe cortical atrophy in the left orbitofrontal cortex and right temporal cortex relative to responders. However, the responders exhibited significantly lower fractional anisotropy values in the bilateral frontal, corpus callosal, and right parietotemporal WM compared with the non-responder group. There were no significant clusters where the cortical thickness or WM alterations were significantly correlated with initial tremor severity or disease duration.

Conclusions: The present data suggest that patients with ET have heterogeneous cortical thinning and WM alteration with respect to responsiveness to propranolol, suggesting that propranolol responsiveness may be a predictive factor to determine ET subtypes in terms of neuroanatomical heterogeneity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Anisotropy
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / pathology*
  • Diffusion Tensor Imaging*
  • Essential Tremor / diagnosis
  • Essential Tremor / drug therapy
  • Essential Tremor / pathology*
  • Essential Tremor / physiopathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Prognosis
  • Propranolol / therapeutic use
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Propranolol

Grants and funding

This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.